Folic acid improves arterial endothelial function in adults with hyperhomocystinemia

被引:254
作者
Woo, KS
Chook, P
Lolin, YI
Sanderson, JE
Metreweli, C
Celermajer, DS
机构
[1] Chinese Univ Hong Kong, Dept Med & Therapeut, Sha Tin 100083, Peoples R China
[2] Chinese Univ Hong Kong, Dept Diagnost Radiol & Organ Imaging, Sha Tin 100083, Peoples R China
[3] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia
关键词
D O I
10.1016/S0735-1097(99)00469-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES To evaluate whether oral folic acid supplementation might improve endothelial function in the arteries of asymptomatic adults with hyperhomocystinemia. BACKGROUND Hyperhomocystinemia is an independent risk factor for endothelial dysfunction and occlusive vascular disease. Folic acid supplementation can lower homocystine levels in subjects with hyperhomocystinemia; however, the effect of this on arterial physiology is not known. METHODS Adults subjects were recruited from a community-based atherosclerosis study on healthy volunteers aged 40 to 70 years who had no history of hypertension, diabetes mellitus, hyperlipidemia, ischemic heart disease or family history of premature atherosclerosis (n = 89). Seventeen subjects (aged 54 +/- 10 years, 15 male) with fasting total homocystine levels above 75th percentile (mean, 9.8 +/- 2.8 mu mol/liter) consented to participate in a double-blind, randomized, placebo-controlled and crossover trial; each subject received oral folic acid (10 mg/day) and placebo for 8 weeks, each separated by a washout period of four weeks. Flow-mediated endothelium-dependent dilation (percent increase in diameter) of the brachial artery was assessed by high resolution ultrasound, before and after folic acid or placebo supplementation. RESULTS Compared with placebo, folic acid supplementation resulted in higher serum folate levels (66.2 +/- 7.0 vs. 29.7 +/- 14.8 nmol/liter; p < 0.001), lower total plasma homocystine levels (8.1 +/- 3.1 vs. 9.5 +/- 2.5 mu mol/liter, p = 0.03) and significant improvement in endothelium dependent dilation (8.2 +/- 1.6% vs. 6 +/- 1.3%, p < 0.001). Endothelium-independent responses to nitroglycerin were unchanged. No adverse events were observed. CONCLUSIONS Folic acid supplementation improves arterial endothelial function in adults with relative hyperhomocystinemia, with potentially beneficial effects on the atherosclerotic process. (C) 1999 by the American College of Cardiology.
引用
收藏
页码:2002 / 2006
页数:5
相关论文
共 29 条
[1]   CLOSE RELATION OF ENDOTHELIAL FUNCTION IN THE HUMAN CORONARY AND PERIPHERAL CIRCULATIONS [J].
ANDERSON, TJ ;
UEHATA, A ;
GERHARD, MD ;
MEREDITH, IT ;
KNAB, S ;
DELAGRANGE, D ;
LIEBERMAN, EH ;
GANZ, P ;
CREAGER, MA ;
YEUNG, AC ;
SELWYN, AP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (05) :1235-1241
[2]   IMPAIRED ENDOTHELIAL FUNCTION OCCURS IN THE SYSTEMIC ARTERIES OF CHILDREN WITH HOMOZYGOUS HOMOCYSTINURIA BUT NOT IN THEIR HETEROZYGOUS PARENTS [J].
CELERMAJER, DS ;
SORENSEN, K ;
RYALLS, M ;
ROBINSON, J ;
THOMAS, O ;
LEONARD, JV ;
DEANFIELD, JE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (03) :854-858
[3]  
Chambers JC, 1998, CIRCULATION, V98, P192
[4]   Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults [J].
Clarkson, P ;
Adams, MR ;
Powe, AJ ;
Donald, AE ;
McCredie, R ;
Robinson, J ;
McCarthy, SN ;
Keech, A ;
Celermajer, DS ;
Deanfield, JE .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (08) :1989-1994
[5]   IS NO AN ENDOGENOUS ANTIATHEROGENIC MOLECULE [J].
COOKE, JP ;
TSAO, PS .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (05) :653-655
[6]   A SHARPER BONFERRONI PROCEDURE FOR MULTIPLE TESTS OF SIGNIFICANCE [J].
HOCHBERG, Y .
BIOMETRIKA, 1988, 75 (04) :800-802
[7]   NITRIC-OXIDE IS RESPONSIBLE FOR FLOW-DEPENDENT DILATATION OF HUMAN PERIPHERAL CONDUIT ARTERIES IN-VIVO [J].
JOANNIDES, R ;
HAEFELI, WE ;
LINDER, L ;
RICHARD, V ;
BAKKALI, EH ;
THUILLEZ, C ;
LUSCHER, TF .
CIRCULATION, 1995, 91 (05) :1314-1319
[8]   PLASMA HOMOCYSTEINE IN ACUTE MYOCARDIAL-INFARCTION - HOMOCYSTEINE-LOWERING EFFECT OF FOLIC-ACID [J].
LANDGREN, F ;
ISRAELSSON, B ;
LINDGREN, A ;
HULTBERG, B ;
ANDERSSON, A ;
BRATTSTROM, L .
JOURNAL OF INTERNAL MEDICINE, 1995, 237 (04) :381-388
[9]   INHIBITION OF THROMBOMODULIN SURFACE EXPRESSION AND PROTEIN-C ACTIVATION BY THE THROMBOGENIC AGENT HOMOCYSTEINE [J].
LENTZ, SR ;
SADLER, JE .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (06) :1906-1914
[10]   Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia [J].
Lentz, SR ;
Sobey, CG ;
Piegors, DJ ;
Bhopatkar, MY ;
Faraci, FM ;
Malinow, MR ;
Heistad, DD .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (01) :24-29